CYDY - Leronlimab update fails to lift CytoDyn shares down 16% September, 17 2020 12:40 PM CytoDyn Inc CytoDyn (OTCQB:CYDY -16.4%) is down on average volume on the heels of its conference call updating its activities related to leronlimab. Key points:More news on: CytoDyn Inc., Healthcare stocks news, Read more ...